title: Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.
authors: Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
authors: G R A
authors: GR
authors: de Mendonça
authors: Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
authors: A B C
authors: AB
authors: Brito
authors: Department of Pathology, AC. Camargo Cancer Center, São Paulo, Brazil.
authors: R M
authors: RM
authors: Rocha
authors: Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil.
authors: M T
authors: MT
authors: Delamain
authors: Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
authors: R
authors: R
authors: de Andrade Natal
authors: Department of Pathology, AC. Camargo Cancer Center, São Paulo, Brazil.
authors: F A
authors: FA
authors: Soares
authors: Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
authors: G W B
authors: GW
authors: Colleoni
authors: Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.|Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil.
authors: C A
authors: CA
authors: Souza
authors: Department of Pathology, AC. Camargo Cancer Center, São Paulo, Brazil.|Laboratory of Molecular and Investigative Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
authors: J
authors: J
authors: Vassallo
authors: Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
authors: C S P
authors: CS
authors: Lima
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016022:Case-Control Studies; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D008224:Lymphoma, Follicular / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D000069283:Rituximab; D016019:Survival Analysis; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone